Certain chemokines inhibit HIV replication through binding to cell surface
receptors which also act as viral coreceptors. Based on our previous observ
ations that HIV-1 Tat can interact with alpha- and beta-chemokine receptors
, we investigated the potential effect of extracellular Tat (ecTat) on infe
ction and replication of CCR5-dependent (R5) and CXCR4-using (X4) HIV-1 str
ains in primary activated peripheral blood mononuclear cells (PBMC) of unin
fected donors. Receptor desensitization and binding competition studies wer
e used to determine chemokine receptor binding by ecTat. Standard HIV repli
cation assays based on reverse transcriptase (RT) activity determination in
culture supernatants of PBMC and real time PCR for HIV-1 gag DNA were used
to determine potential effects on early (entry or RT) steps of infection.
ecTat bound to CXCR4 expressing monocytes and mitogen-activated PBMC, and c
ompeted with the natural ligand of CXCR4, SDF-1 alpha (stromal cell-derived
factor-1 alpha) in calcium mobilization assays. EcTat inhibited replicatio
n of the X4 HIV-1 (LAI/IIIB strain) in activated PBMC at concentrations clo
se to those of SDF-1 alpha; whereas it only modestly interfered with R5 HIV
-1 (BaL) replication in PBMC. Both SDF-1 alpha and ecTat inhibited accumula
tion of X4 HIV-1 gag DNA, indicating interference with viral entry and/or R
T. Our data show the surprising and counter-intuitive observation that ecTa
t selectively represses X4 HIV replication. This could favour spreading of
R5 viruses, a condition observed in vivo immediately after transmission and
in the early asymptomatic phase of infection. (C) 2000 Academic Press.